Prevalence of Neuropsychiatric Symptoms in Alzheimer’s Disease and Vascular Dementia

2013 ◽  
pp. 260-280
2019 ◽  
Vol 13 (3) ◽  
pp. 293-298 ◽  
Author(s):  
Chan Tiel ◽  
Felipe Kenji Sudo ◽  
Ana Beatriz Calmon

ABSTRACT Neuropsychiatric symptoms (NPS) in dementia are prevalent, under-recognized and little studied regarding their pathophysiological aspects. The pathophysiological mechanism, as well as the possible role of vascular lesions in the genesis of these symptoms, are still matters of debate. Objective: to describe and compare the prevalence and severity of NPS in subjects with Alzheimer's disease (AD) and vascular dementia (VaD). Methods: a cross-sectional study involving 82 outpatients, divided into two groups (AD × VaD), was conducted. Patients were submitted to the Cambridge Cognitive Test (CAMCOG), the Clock Drawing Test (CLOX 1 and 2), the Neuropsychiatric Inventory (NPI) and the Clinical Dementia Rating (CDR) scale. Neuroimaging was scored using the de Leon and Fazekas scales. Results: 90.8% of the patients had at least one neuropsychiatric symptom. There were statistical differences on the CLOX test and in the apathy symptoms between AD and VaD groups. Apathy and disinhibition proved more prevalent in patients with higher vascular load. Conclusion: apathy and impaired executive function may reflect vascular damage in subcortical circuits in dementia patients.


2019 ◽  
Vol 216 (1) ◽  
pp. 1-3 ◽  
Author(s):  
George Savulich ◽  
John T. O'Brien ◽  
Barbara J. Sahakian

SummaryAlzheimer's disease and vascular dementia are associated with overlapping symptoms of anxiety and depression. More accurate discrimination between emerging neuropsychiatric and cognitive symptoms would better assist illness detection. The potential for protection against cognitive decline and dementia following early identification and intervention of neuropsychiatric symptoms warrants investigation.


2013 ◽  
Vol 33 (3) ◽  
pp. 715-721 ◽  
Author(s):  
Carmen Echávarri ◽  
Saartje Burgmans ◽  
Harry Uylings ◽  
Manuel J. Cuesta ◽  
Victor Peralta ◽  
...  

2012 ◽  
Vol 9 (6) ◽  
pp. 759-771 ◽  
Author(s):  
Grazia D'Onofrio ◽  
Daniele Sancarlo ◽  
Francesco Panza ◽  
Massimiliano Copetti ◽  
Leandro Cascavilla ◽  
...  

2013 ◽  
Vol 9 ◽  
pp. P525-P526
Author(s):  
Amardeep Saund ◽  
Cassandra Anor ◽  
David Tang-Wai ◽  
Ron Keren ◽  
Maria Carmela Tartaglia

Author(s):  
Burbaeva G.Sh. ◽  
Androsova L.V. ◽  
Vorobyeva E.A. ◽  
Savushkina O.K.

The aim of the study was to evaluate the rate of polymerization of tubulin into microtubules and determine the level of colchicine binding (colchicine-binding activity of tubulin) in the prefrontal cortex in schizophrenia, vascular dementia (VD) and control. Colchicine-binding activity of tubulin was determined by Sherlinе in tubulin-enriched extracts of proteins from the samples. Measurement of light scattering during the polymerization of the tubulin was carried out using the nephelometric method at a wavelength of 450-550 nm. There was a significant decrease in colchicine-binding activity and the rate of tubulin polymerization in the prefrontal cortex in both diseases, and in VD to a greater extent than in schizophrenia. The obtained results suggest that not only in Alzheimer's disease, but also in other mental diseases such as schizophrenia and VD, there is a decrease in the level of tubulin in the prefrontal cortex of the brain, although to a lesser extent than in Alzheimer's disease, and consequently the amount of microtubules.


Sign in / Sign up

Export Citation Format

Share Document